Angiotech to participate in Credit Suisse Global Leveraged Finance Conference



    VANCOUVER, March 20 /CNW/ - Angiotech Pharmaceuticals, Inc. (NASDAQ:  
ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company,
is scheduled to participate in the Credit Suisse Global Leveraged Finance
Conference, which is being held March 24-27 in Phoenix, Arizona.
    Mr. Thomas Bailey, Angiotech's Chief Financial Officer, is scheduled to
present on Wednesday, March 26, beginning at approximately 8:00 am Mountain
Time. A question and answer session will immediately follow the presentation.
    Presentations at this conference will not be webcast. More information is
available on the Angiotech website (www.angiotech.com) under the Investors
section.

    About Angiotech

    Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and
medical device company with over 1,500 dedicated employees. Angiotech
discovers, develops and markets innovative treatment solutions for diseases or
complications associated with medical device implants, surgical interventions
and acute injury. To find out more about Angiotech (NASDAQ:   ANPI, TSX: ANP),
please visit our website at www.angiotech.com.




For further information:

For further information: Deirdre Neary, Manager, Investor Relations,
Angiotech Pharmaceuticals, Inc., (604) 222-7056, dneary@angio.com

Organization Profile

Angiotech Pharmaceuticals, Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890